USANA Health Sciences, Inc. (USNA)
USNA Stock Price Chart
Explore USANA Health Sciences, Inc. interactive price chart. Choose custom timeframes to analyze USNA price movements and trends.
USNA Company Profile
Discover essential business fundamentals and corporate details for USANA Health Sciences, Inc. (USNA) to support your stock research and investment decisions.
Sector
Consumer Defensive
Industry
Household & Personal Products
IPO Date
4 Apr 1994
Employees
1.57k
Website
https://www.usana.comCEO
Kevin G. Guest
Description
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
USNA Financial Timeline
Browse a chronological timeline of USANA Health Sciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Aug 2026
EPS estimate is $0.43, while revenue estimate is $235.00m.
Earnings released on 5 May 2026
EPS came in at $0.61 surpassing the estimated $0.44 by +38.64%, while revenue for the quarter reached $250.00m , beating expectations by +3.74%.
Earnings released on 17 Feb 2026
EPS came in at $0.60 surpassing the estimated $0.41 by +46.34%, while revenue for the quarter reached $226.20m , beating expectations by +0.11%.
Earnings released on 21 Oct 2025
EPS came in at -$0.15 falling short of the estimated $0.25 by -160.00%, while revenue for the quarter reached $213.67m , missing expectations by -2.81%.
Earnings released on 22 Jul 2025
EPS came in at $0.74 surpassing the estimated $0.54 by +37.04%, while revenue for the quarter reached $235.85m , beating expectations by +4.44%.
Earnings released on 22 Apr 2025
EPS came in at $0.73 surpassing the estimated $0.70 by +4.29%, while revenue for the quarter reached $249.54m , beating expectations by +13.24%.
Earnings released on 25 Feb 2025
EPS came in at $0.64 surpassing the estimated $0.49 by +30.61%, while revenue for the quarter reached $213.61m , beating expectations by +2.29%.
Earnings released on 22 Oct 2024
EPS came in at $0.56 surpassing the estimated $0.49 by +14.29%, while revenue for the quarter reached $200.22m , missing expectations by -4.13%.
Earnings released on 23 Jul 2024
EPS came in at $0.54 falling short of the estimated $0.65 by -16.92%, while revenue for the quarter reached $212.87m , missing expectations by -3.69%.
Earnings released on 30 Apr 2024
EPS came in at $0.86 surpassing the estimated $0.69 by +24.64%, while revenue for the quarter reached $227.80m , beating expectations by +0.42%.
Earnings released on 6 Feb 2024
EPS came in at $0.87 surpassing the estimated $0.52 by +67.31%, while revenue for the quarter reached $221.08m , beating expectations by +4.09%.
Earnings released on 24 Oct 2023
EPS came in at $0.59 falling short of the estimated $0.64 by -7.81%, while revenue for the quarter reached $213.37m , missing expectations by -3.20%.
Earnings released on 25 Jul 2023
EPS came in at $0.89 surpassing the estimated $0.70 by +27.14%, while revenue for the quarter reached $238.20m , beating expectations by +3.06%.
Earnings released on 25 Apr 2023
EPS came in at $0.95 surpassing the estimated $0.77 by +23.38%, while revenue for the quarter reached $248.36m , missing expectations by -2.93%.
Earnings released on 7 Feb 2023
EPS came in at $0.66 surpassing the estimated $0.35 by +88.57%, while revenue for the quarter reached $227.96m , beating expectations by +11.85%.
Earnings released on 25 Oct 2022
EPS came in at $0.78 falling short of the estimated $0.89 by -12.36%, while revenue for the quarter reached $233.30m , missing expectations by -4.46%.
Earnings released on 26 Jul 2022
EPS came in at $1.00 falling short of the estimated $1.14 by -12.28%, while revenue for the quarter reached $264.47m , missing expectations by -0.20%.
Earnings released on 26 Apr 2022
EPS came in at $1.15 surpassing the estimated $1.14 by +0.88%, while revenue for the quarter reached $272.87m , beating expectations by +2.08%.
Earnings released on 8 Feb 2022
EPS came in at $1.03 falling short of the estimated $1.28 by -19.53%, while revenue for the quarter reached $267.30m , missing expectations by -1.70%.
Earnings released on 26 Oct 2021
EPS came in at $1.36 surpassing the estimated $1.30 by +4.62%, while revenue for the quarter reached $274.35m , missing expectations by -9.53%.
Earnings released on 27 Jul 2021
EPS came in at $1.87 surpassing the estimated $1.72 by +8.72%, while revenue for the quarter reached $336.84m , beating expectations by +11.08%.
USNA Stock Performance
Access detailed USNA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
